Intrathecal (IT) and intravenous (IV) nivolumab (N) for metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD).
Ida John, Alexandra P. Foster,Cara L. Haymaker,Roland L. Bassett,J. Jack Lee, Michelle L. Rohlfs,Jessie Richard,Masood Iqbal,Ian E. McCutcheon,Sherise D. Ferguson,Amy B. Heimberger,Chantal M. Saberian, Barbara Jane O'Brien,Sudhakar Tummala,Nandita Guha-Thakurta,Matthew Debnam,Hussein Abdul-Hassan Tawbi,Elizabeth M. Burton,Michael A. Davies, Isabella Claudia Glitza JOURNAL OF CLINICAL ONCOLOGY（2021）
AI 理解论文
溯源树
样例
